On Friday, Cathie Wooden-led Ark Make investments made vital trades involving Beam Therapeutics Inc. BEAM, Nu Holdings Ltd. NU, MercadoLibre Inc. MELI, and Adaptive Biotechnologies Corp. ADPT.
The BEAM Commerce
Ark Make investments, by means of its ARK Genomic Revolution ETF ARKG and ARK Innovation ETF ARKK, purchased a complete of 24,640 shares of Beam Therapeutics.
This comes after the agency’s earlier acquisition of Beam Therapeutics shares only a week prior. The worth of this commerce, calculated from the newest closing value is almost $750,000.
The NU Commerce
Ark Make investments, by means of its ARK Fintech Innovation ETF ARKF, purchased 162,143 shares of Nu Holdings Ltd. This marks a big funding within the fintech firm, reflecting Ark’s strategic positioning within the dynamic tech sector.
The worth of this commerce, calculated from the newest closing value is over $1.75 million.
The MELI and ADPT Trades
On the identical day, Ark Make investments additionally offered shares of MercadoLibre Inc and Adaptive Biotechnologies Corp. By means of its ARK Fintech Innovation ETF, Ark offered 347 shares of MercadoLibre.
In the meantime, by means of its ARK Genomic Revolution ETF, Ark offloaded 8,129 shares of Adaptive Biotechnologies.
Learn Subsequent:
Disclaimer: This content material was partially produced with the assistance of AI instruments and was reviewed and revealed by Benzinga editors.
Photograph courtesy: Ark Make investments
Market Information and Knowledge dropped at you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
